Numinus Wellness Inc (NUMIF)

[barnyarddog]

Our company

Numinus is an integrated mental health company creating an ecosystem of health solutions to research, develop, and deliver safe, evidence-based, accessible psychedelic-assisted psychotherapy.

Numinus Bioscience is a Health Canada-licensed lab for psychedelic substance research, developing IP while offering analytics services for revenue generation.

Numinus R&D is developing psychedelic-assisted therapeutic protocols to embed in mainstream healthcare, led by medical leadership with global research and policy reform experience.

Numinus Health delivers treatments to patients through clinics and virtual services, for physical, mental, and emotional healing

https://numinus.ca/investors

Special Access for psilocybin & MDMA

Pending approval of regulatory change, Numinus intends to support patients in obtaining Special Access to psychedelic-assisted psychotherapies for a range of conditions, to be offered through our clinics in Vancouver and Montreal.

Health Canada has posted its Notice of Intent, subject to public consultation, to revise its Special Access Programme to allow legal access to psilocybin and MDMA outside of clinical trials, while the substances await formal approvals.


Numinus is undertaking two compassionate access clinical trials, which will be conducted in our Vancouver clinic. Both trials will be open to Canadian participants.

MDMA-assisted psychotherapy for PTSD, in collaboration with psychedelic research pioneer MAPS
Psilocybin-assisted psychotherapy for substance use disorders

https://numinus.ca/clinics